U.S. flag

An official website of the United States government

NM_000256.3(MYBPC3):c.1091C>T (p.Ala364Val) AND Hypertrophic cardiomyopathy

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jan 13, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001857025.3

Allele description [Variation Report for NM_000256.3(MYBPC3):c.1091C>T (p.Ala364Val)]

NM_000256.3(MYBPC3):c.1091C>T (p.Ala364Val)

Gene:
MYBPC3:myosin binding protein C3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p11.2
Genomic location:
Preferred name:
NM_000256.3(MYBPC3):c.1091C>T (p.Ala364Val)
HGVS:
  • NC_000011.10:g.47343624G>A
  • NG_007667.1:g.14079C>T
  • NM_000256.3:c.1091C>TMANE SELECT
  • NP_000247.2:p.Ala364Val
  • LRG_386t1:c.1091C>T
  • LRG_386:g.14079C>T
  • LRG_386p1:p.Ala364Val
  • NC_000011.9:g.47365175G>A
Protein change:
A364V
Links:
dbSNP: rs778161908
NCBI 1000 Genomes Browser:
rs778161908
Molecular consequence:
  • NM_000256.3:c.1091C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hypertrophic cardiomyopathy
Synonyms:
HYPERTROPHIC MYOCARDIOPATHY
Identifiers:
MONDO: MONDO:0005045; MeSH: D002312; MedGen: C0007194; Human Phenotype Ontology: HP:0001639

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002208279Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jan 13, 2024)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy.

Melacini P, Basso C, Angelini A, Calore C, Bobbo F, Tokajuk B, Bellini N, Smaniotto G, Zucchetto M, Iliceto S, Thiene G, Maron BJ.

Eur Heart J. 2010 Sep;31(17):2111-23. doi: 10.1093/eurheartj/ehq136. Epub 2010 May 31.

PubMed [citation]
PMID:
20513729
PMCID:
PMC2930982

Rapid detection of genetic variants in hypertrophic cardiomyopathy by custom DNA resequencing array in clinical practice.

Fokstuen S, Munoz A, Melacini P, Iliceto S, Perrot A, Ozcelik C, Jeanrenaud X, Rieubland C, Farr M, Faber L, Sigwart U, Mach F, Lerch R, Antonarakis SE, Blouin JL.

J Med Genet. 2011 Aug;48(8):572-6. doi: 10.1136/jmg.2010.083345. Epub 2011 Jan 14.

PubMed [citation]
PMID:
21239446
See all PubMed Citations (5)

Details of each submission

From Invitae, SCV002208279.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 364 of the MYBPC3 protein (p.Ala364Val). This variant is present in population databases (rs778161908, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with MYBPC3-related conditions. ClinVar contains an entry for this variant (Variation ID: 432853). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant disrupts the p.Ala364 amino acid residue in MYBPC3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 20513729, 21239446, 21302287, 25740977). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024